
### [MONDO:0018400](http://purl.obolibrary.org/obo/MONDO_0018400)
**Label:** rare female infertility due to an adrenal disorder

**Subclasses:** [MONDO:0020528](http://purl.obolibrary.org/obo/MONDO_0020528) (ACTH-dependent Cushing syndrome), [MONDO:0008728](http://purl.obolibrary.org/obo/MONDO_0008728) (classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency), [MONDO:0020529](http://purl.obolibrary.org/obo/MONDO_0020529) (ACTH-independent Cushing syndrome), [MONDO:0019597](http://purl.obolibrary.org/obo/MONDO_0019597) (46,XY disorder of sex development due to isolated 17,20-lyase deficiency), [MONDO:0008730](http://purl.obolibrary.org/obo/MONDO_0008730) (congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency), [MONDO:0015460](http://purl.obolibrary.org/obo/MONDO_0015460) (adrenocortical carcinoma), [MONDO:0015999](http://purl.obolibrary.org/obo/MONDO_0015999) (primary pigmented nodular adrenocortical disease), [MONDO:0008725](http://purl.obolibrary.org/obo/MONDO_0008725) (congenital lipoid adrenal hyperplasia due to STAR deficency), [MONDO:0018627](http://purl.obolibrary.org/obo/MONDO_0018627) (ACTH-independent Cushing syndrome due to rare cortisol-producing adrenal tumor), 

**Corr. equiv. classes:** [Orphanet:99892](http://www.orpha.net/ORDO/Orphanet_99892), [Orphanet:99893](http://www.orpha.net/ORDO/Orphanet_99893), [OMIM:201910](http://purl.obolibrary.org/obo/OMIM_201910), [OMIM:201710](http://purl.obolibrary.org/obo/OMIM_201710), [OMIM:614190](http://purl.obolibrary.org/obo/OMIM_614190), [OMIM:202300](http://purl.obolibrary.org/obo/OMIM_202300), [OMIM:202110](http://purl.obolibrary.org/obo/OMIM_202110), [Orphanet:90796](http://www.orpha.net/ORDO/Orphanet_90796), [OMIM:615830](http://purl.obolibrary.org/obo/OMIM_615830), [Orphanet:189439](http://www.orpha.net/ORDO/Orphanet_189439), [OMIM:610475](http://purl.obolibrary.org/obo/OMIM_610475), [OMIM:610489](http://purl.obolibrary.org/obo/OMIM_610489), [Orphanet:418](http://www.orpha.net/ORDO/Orphanet_418), [Orphanet:90790](http://www.orpha.net/ORDO/Orphanet_90790), [Orphanet:90793](http://www.orpha.net/ORDO/Orphanet_90793), [Orphanet:1501](http://www.orpha.net/ORDO/Orphanet_1501), [Orphanet:443287](http://www.orpha.net/ORDO/Orphanet_443287), [Orphanet:95698](http://www.orpha.net/ORDO/Orphanet_95698), [Orphanet:90794](http://www.orpha.net/ORDO/Orphanet_90794), 

**Class expressions from DL-Learner:**

- [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 63.16%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) 63.16%
- [HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) 63.16%
- [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) and [HP:0010461](http://purl.obolibrary.org/obo/HP_0010461) (Abnormality of the male genitalia) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 63.16%
- [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 63.16%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) and [HP:0010936](http://purl.obolibrary.org/obo/HP_0010936) (Abnormality of the lower urinary tract) 63.16%
- [HP:0000811](http://purl.obolibrary.org/obo/HP_0000811) (Abnormal external genitalia) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 63.16%
- [HP:0000795](http://purl.obolibrary.org/obo/HP_0000795) (Abnormality of the urethra) and [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) 63.16%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) and [HP:0010461](http://purl.obolibrary.org/obo/HP_0010461) (Abnormality of the male genitalia) 63.16%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 63.16%
- [HP:0000771](http://purl.obolibrary.org/obo/HP_0000771) (Gynecomastia) and [HP:0000811](http://purl.obolibrary.org/obo/HP_0000811) (Abnormal external genitalia) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) 63.16%
- [HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) and [HP:0010461](http://purl.obolibrary.org/obo/HP_0010461) (Abnormality of the male genitalia) 63.16%
- [HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) and [HP:0008373](http://purl.obolibrary.org/obo/HP_0008373) (Puberty and gonadal disorders) 63.16%
- [HP:0000769](http://purl.obolibrary.org/obo/HP_0000769) (Abnormality of the breast) and [HP:0000811](http://purl.obolibrary.org/obo/HP_0000811) (Abnormal external genitalia) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) 63.16%
- [HP:0000032](http://purl.obolibrary.org/obo/HP_0000032) (Abnormality of male external genitalia) and [HP:0008221](http://purl.obolibrary.org/obo/HP_0008221) (Adrenal hyperplasia) and [HP:0031093](http://purl.obolibrary.org/obo/HP_0031093) (Abnormal breast morphology) 63.16%


